The Matricellular Protein R-Spondin 2 Promotes Midbrain Dopaminergic Neurogenesis and Differentiation.
The Matricellular Protein R-Spondin 2 Promotes Midbrain Dopaminergic Neurogenesis and Differentiation.
复制标题
DOI:
10.1016/j.stemcr.2018.07.014
复制
发表时间:
2018-09-11
影响因子:
5.9
通讯作者:
Arenas E
中科院分区:
文献类型:
--
作者:
Gyllborg D;Ahmed M;Toledo EM;Theofilopoulos S;Yang S;Ffrench-Constant C;Arenas E
The development of midbrain dopaminergic (mDA) neurons is controlled by multiple morphogens and transcription factors. However, little is known about the role of extracellular matrix proteins in this process. Here we examined the function of roof plate-specific spondins (RSPO1-4) and the floor plate-specific, spondin 1 (SPON1). Only RSPO2 and SPON1 were expressed at high levels during mDA neurogenesis, and the receptor LGR5 was expressed by midbrain floor plate progenitors. Surprisingly, RSPO2, but not SPON1, specifically promoted the differentiation of mDA neuroblasts into mDA neurons in mouse primary cultures and embryonic stem cells (ESCs). In addition, RSPO2 was found to promote not only mDA differentiation, but also mDA neurogenesis in human ESCs. Our results thus uncover an unexpected function of the matricellular protein RSPO2 and suggest an application to improve mDA neurogenesis and differentiation in human stem cell preparations destined to cell replacement therapy or drug discovery for Parkinson disease. Rspo2 is dynamically expressed during midbrain dopaminergic neuron development RSPO2 promotes the dopaminergic differentiation of mouse neurons in culture RSPO2 increases dopaminergic neurogenesis and differentiation of human ESCs Gyllborg and colleagues report on the function of the matricellular protein R-Spondin 2 (RSPO2) in dopaminergic neuron development. RSPO2 is dynamically expressed during midbrain development and promotes the dopaminergic differentiation of mouse and human neuroblasts. Furthermore, they show that RSPO2 induced dopaminergic neurogenesis in human stem cell cultures, suggesting a possible application of RSPO2 in cell replacement strategies for Parkinson disease.
登录
查看更多内容
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
3.7
作者:
Hoekstra EJ;von Oerthel L;van der Heide LP;Kouwenhoven WM;Veenvliet JV;Wever I;Jin YR;Yoon JK;van der Linden AJ;Holstege FC;Groot Koerkamp MJ;Smidt MP
通讯作者:
Smidt MP
影响因子:
10.5
作者:
de Lau W;Peng WC;Gros P;Clevers H
通讯作者:
Clevers H
影响因子:
4.6
作者:
Bell, Sheila M.;Schreiner, Claire M.;Whitsett, Jeffrey A.
通讯作者:
Whitsett, Jeffrey A.
影响因子:
8.8
作者:
Barker, Nick;Rookmaaker, Maarten B.;Clevers, Hans
通讯作者:
Clevers, Hans